Long term, tamoxifen stops more cancer than Evista
Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co’s Evista, but with a greater risk of some other cancers and blood clots.
Read more on Reuters via Yahoo! News
Breast cancer is the second leading cause of cancer death in women in the United States, with approximately 180,000 cases diagnosed each year. Researchers continue to evaluate environmental factors, such as diet, that influence the development of breast cancer. Numerous studies have provided a wealth of often-contradictory information about the detrimental and protective factors of different foods. High fruit and vegetable consumption has been associated with a reduced risk for developing at least 10 different cancers. Studies evaluating the influence of diet on breast cancer prognosis have produced inconsistent results.
Researchers from California and Utah assessed a cohort of 1,901 women from the Life After Cancer Epidemiology (LACE) Study who were diagnosed with early-stage breast cancer between 1997 and 2000. Upon entering the study, the women completed a food frequency questionnaire (FFQ). The researchers used the data from the FFQs to identify two dietary patterns among the women: a prudent diet included high intakes of fruits, vegetables, whole grains, and poultry, whereas a Western diet included high intakes of red and processed meats and refined grains. The researchers then evaluated the rates of recurrence, overall death, death from breast cancer, and death from causes other than breast cancer. As of May 2008, there were 268 breast cancer recurrences and 226 deaths, 128 of which were attributed to breast cancer.
» Read more: Terramed Alliance News Healthy Diet Can’t Hurt, May Help Breast Cancer Patients
The Prostate Specific Antigen known as PSA are protein formed by the prostate glands that is basically originated from the blood. A man suffering from a prostate cancer has a higher PSA levels compared to normal. Prostate specific antigen test was prepared to determine the height of PSA forming to blood. Using this test was permitted by FDA to distinguish the existence of this cancerous disease with the elderly men. Prostate cancer PSA testing was likewise accepted by FDA with those patients who have a prior history to be able to check the possible comeback of the disease.
When a man is suspected to have a higher level of PSA, it’s probably the cancer has occurred. Even though, there might be another reason for the rising of the PSA. A number of factors were taken to consideration by the doctors on taking the prostate cancer PSA test, blood samples can be typically taken throughout the prostate cancer PSA test and amount is can be measured in the laboratory. PSA was also named as the “tumor marker” or rather the “biological marker” for the reason that it was utilized for detection of the diseases and was created by body the cells.
» Read more: Prostate Cancer PSA